ArticleClinical pharmacology in drug development2021

Results of a Dose-Finding Phase 1b Study of Subcutaneous Atezolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer.

Enriqueta Felip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.